Saturday, January 31, 2026

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

North Korea Sends $2 Million in Scholarships to Japan-Based Pro-Pyongyang Group

Kim Jong Un donated $2 million to support education for Korean children in Japan, marking Kim Il Sung's birthday anniversary.

Why 1 Billion People Are Suffering from Migraines and What You Can Do About It

A woman in her 30s with severe migraines can manage symptoms with new oral CGRP-targeted treatments and personalized care.

Tag: Sweet Dreams

No posts to display

Top News

- Our Sponsors Ad -

Follow us